Unlocking the Potential of Nose-to-Brain Biologic Delivery for Neuroprotection in CNS Disorders
12:00 pm - Wednesday 3rd February 2027
- Exploring how intranasal delivery can bypass the blood-brain barrier to enable direct access to the central nervous system
- Examining the opportunities and challenges of developing potent biologics for neurodegenerative diseases including Alzheimer’s, Parkinson’s, and ALS
- Understanding the scientific, clinical, and commercial considerations needed to drive broader adoption of nose-to-brain therapeutics
